Up a level |
Jump to: 2017
Number of items: 1.
2017
Kunz, D., Froetschl, R., Timmer, M., Roehn, G., Weickhardt, S., Eckstein, N. and Haas, B. (2017). Inhibition of PI3K but not RAS signalling re-sensitizes GBM cells towards temozolomide. Naunyn-Schmiedebergs Arch. Pharmacol., 390. S. S64 - 1. NEW YORK: SPRINGER. ISSN 1432-1912